Medico Intercontinental Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Medico Intercontinental Ltd. on BSE

Load latest

Medico Intercontinental Ltd.

15 Feb 2023

39.51

-1.18%

Company Update

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

We hereby wish to inform you that the unaudited financial results (Standalone & Consolidated) for the quarter and nine months ended 31st December, 2022 were approved at the meeting of Board of Directors held on Tuesday, 14th February, 2023. In continuation to the same, the newspaper clipping duly published in English and Gujarati Newspaper is enclosed herewith.

pdf

Medico Intercontinental Ltd.

14 Feb 2023

39.51

-1.18%

Company Update

Medico Intercontinental Ltd - 539938 - Statement On Deviation Or Variation Of Funds Raised Though Preferential …

BSE India

Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended read with SEBI Circular No. CIR/ CFD/CMD1/162/2019 dated December 24, 2019, we hereby confirm that during the quarter ended December 31, 2022, there was no deviation or variation in the utilization of proceeds of the preferential issue of Equity shares from the objects as stated in the PAS-4. A statement of deviation or variation for the quarter ended December 31, 2022, duly reviewed by the Audit Committee of the Company is enclosed as 'Annexure'. This disclosure will also be hosted on the Company''s website viz. www.medicointercontinental.com

pdf

Medico Intercontinental Ltd.

14 Feb 2023

39.51

-1.18%

Result

Medico Intercontinental Ltd - 539938 - Results - Financial Results For Quarter And Nine Months Ended …

BSE India

Pursuant to provisions of Regulation 30 and 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., February 14, 2023, inter alia, considered and approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on December 31, 2022 along with Limited Review Report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. Further, please find enclosed 'Unaudited Standalone and Consolidated Financial Results along with Limited Review Report' for the quarter and nine months ended on December 31, 2022 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.com The Board Meeting of the Company commenced at 12:30 PM and concluded at 01:30 PM.

pdf

Medico Intercontinental Ltd.

14 Feb 2023

39.51

-1.18%

Board Meeting

Medico Intercontinental Ltd - 539938 - Board Meeting Outcome for Board Meeting And Compliances Of Regulation …

BSE India

pdf

Medico Intercontinental Ltd.

07 Feb 2023

39.51

-1.18%

Board Meeting

Medico Intercontinental Ltd - 539938 - Board Meeting Intimation for Board Meeting In Compliance Of Regulation …

BSE India

Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 ,inter alia, to consider and approve With reference to the captioned subject, we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 14th February, 2023 at the registered office of the Company situated at 1-5th Floor, Aditraj Arcade, Nr Karma Shreshtha Tower, 100 Ft Rd, Satellite, Ahmedabad, Gujarat - 380015, to inter alia consider, approve and take on record the unaudited Financial Results (Standalone and Consolidated) for quarter and nine months ended 31st December, 2022 and any other business items as per agenda circulated.

pdf

Medico Intercontinental Ltd.

06 Jan 2023

39.51

-1.18%

Company Update

Medico Intercontinental Ltd - 539938 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

We are enclosing herewith the Confirmation Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st December, 2022.

pdf

Medico Intercontinental Ltd.

31 Dec 2022

39.51

-1.18%

SAST

Medico Intercontinental Ltd - 539938 - Closure of Trading Window

BSE India

Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and in compliance with circular no. LIST/COMP/01/2019-20 dated 2nd April, 2019 issued by BSE Limited, we wish to inform you that the 'Trading Window' for dealing in the securities of the Company has been closed and shall remain closed for all the designated persons and their immediate relatives till the conclusion of 48 hours after the declaration of financial results of the company for the quarter and nine months ended December 31, 2022. Accordingly, all designated persons and their immediate relatives of the Company have been advised not to trade in the securities of the Company during the aforesaid period of closure of trading window.

pdf

Medico Intercontinental Ltd.

17 Nov 2022

39.51

-1.18%

Company Update

Medico Intercontinental Ltd - 539938 - Request For Change In Details Under 'Corporate Information Tab' On …

BSE India

With respect to above mentioned subject and pursuant to earlier announcement / outcome given on 22nd August, 2022 and 14th November, 2022 and our earlier letters provided dated 10th May, 2019, 13th December, 2019, 27th June, 2022, we would like to request you to kindly update Corporate Information Tab of our Company on the website of BSE. The Changes are required to be made as per attached PDF.

pdf

Medico Intercontinental Ltd.

15 Nov 2022

39.51

-1.18%

Company Update

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

We hereby wish to inform you that the unaudited financial results (Standalone & Consolidated) for the quarter and half year ended 30th September, 2022 were approved at the meeting of Board of Directors held on Monday, 14th November, 2022. In continuation to the same, the newspaper clipping duly published in English and Gujarati Newspaper is enclosed herewith.

pdf

Medico Intercontinental Ltd.

15 Nov 2022

39.51

-1.18%

Result

Medico Intercontinental Ltd - 539938 - Declaration Regarding Regulation 23 (9) Of SEBI (Listing Obligations And …

BSE India

As per the provisions of 15(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('LODR Regulations'), the compliances with corporate governance provisions as specified in Regulations 17 to 27 are applicable to the Company only if it's paid up Capital exceeds Rs. 10 Crores and if Net worth is above Rs. 25 Crores. As on 31st March, 2022, the paid up share capital of the company is Rs. 3,24,90,000/- which does not exceed Rs. 10 Crores limit and the Net Worth of the Company is Rs. 7,65,20,109/- (Rupees Seven Crores Sixty Five Lakhs Twenty thousand One Hundred and Nine only) which does not cross Rs. 25 Crores. Hence, the compliance of provisions of Regulations 17 to 27 of SEBI (LODR) Regulations, 2015 is not applicable to the Company for the quarter and half year ended 30th September, 2022. In light of the above, the Company do not fall under the ambit of Regulation 23 (9) of SEBI (LODR) Regulations, 2015.

pdf

Is Medico Intercontinental Ltd. worth buying?

33 Votes:

Buy 75.76%

Sell 12.12%

Hold 12.12%